Saline From Otrivin Nasal Drops
Natural health product licensed in Canada
- Licence holder
- Novartis Consumer Health Canada Inc.
- NPN or DIN-HM
- 00857777
- Status
- Inactive licence
- Licence date
- 5 November 2007
- Revision date
- Not provided
- Form
- Gouttes
- Route of administration
- Nasale
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Chlorure de sodium | 0.7 % |
Non-medicinal ingredients
Monosodium Phosphate, phosphate dibasique de sodium, Hydroxypropylméthylcellulose, Sorbitol, Edetate Disodium, Chlorure de benzalkonium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | 1 Goutte(s) | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adultes | Not specified | minimum: 2 Goutte(s) ; maximum: 3 Goutte(s) | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Moisturise nasal passages and provide soothing and effective relief from a dry, irritated nose.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 00857777
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.